Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Up 9.9% – Time to Buy?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) traded up 9.9% on Wednesday . The stock traded as high as $1.00 and last traded at $1.00. Approximately 231 shares traded hands during trading, a decline of 97% from the average daily volume of 9,053 shares. The stock had previously closed at $0.91.

Peak Pharmaceuticals Stock Up 9.9%

The stock has a fifty day simple moving average of $0.89 and a two-hundred day simple moving average of $1.50.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Stories

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.